BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 15205923)

  • 21. Pharmacokinetics and intracellular distribution of the tumor-targeted radiopharmaceutical m-iodo-benzylguanidine in SK-N-SH neuroblastoma and PC-12 pheochromocytoma cells.
    Smets LA; Janssen M; Rutgers M; Ritzen K; Buttenhuis C
    Int J Cancer; 1991 Jun; 48(4):609-15. PubMed ID: 2045205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 99mTc-labeled MIBG derivatives: novel 99mTc complexes as myocardial imaging agents for sympathetic neurons.
    Zhuang ZP; Kung MP; Mu M; Hou C; Kung HF
    Bioconjug Chem; 1999; 10(2):159-68. PubMed ID: 10077463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved selectivity of mIBG uptake into neuroblastoma cells in vitro and in vivo by inhibition of organic cation transporter 3 uptake using clinically approved corticosteroids.
    Bayer M; Schmitt J; Dittmann H; Handgretinger R; Bruchelt G; Sauter AW
    Nucl Med Biol; 2016 Sep; 43(9):543-551. PubMed ID: 27376201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imaging the norepinephrine transporter in neuroblastoma: a comparison of [18F]-MFBG and 123I-MIBG.
    Zhang H; Huang R; Cheung NK; Guo H; Zanzonico PB; Thaler HT; Lewis JS; Blasberg RG
    Clin Cancer Res; 2014 Apr; 20(8):2182-91. PubMed ID: 24573553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro and in vivo studies with no-carrier added radioiodinated MIBG.
    Franceschini R; Pecorale A; Chinol M; Calcagni ML; Servidei T; Riccardi R; Troncone L
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):72-7. PubMed ID: 9002755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Active uptake and extravesicular storage of m-iodobenzylguanidine in human neuroblastoma SK-N-SH cells.
    Smets LA; Loesberg C; Janssen M; Metwally EA; Huiskamp R
    Cancer Res; 1989 Jun; 49(11):2941-4. PubMed ID: 2720653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of phenylpiperazines as targeting agents for neuroblastoma.
    Babich JW; Graham WA; Fischman AJ
    Br J Cancer; 1996 Sep; 74(6):917-24. PubMed ID: 8826858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased MIBG uptake after transfer of the human norepinephrine transporter gene in rat hepatoma.
    Altmann A; Kissel M; Zitzmann S; Kübler W; Mahmut M; Peschke P; Haberkorn U
    J Nucl Med; 2003 Jun; 44(6):973-80. PubMed ID: 12791828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pinhole imaging of 131I-metaiodobenzylguanidine (131I-MIBG) in an animal model of neuroblastoma.
    Accorsi R; Morowitz MJ; Charron M; Maris JM
    Pediatr Radiol; 2003 Oct; 33(10):688-92. PubMed ID: 12908090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meta-[123I]iodobenzylguanidine is selectively radiotoxic to neuroblastoma cells at concentrations that spare cells of haematopoietic lineage.
    He Y; Das B; Baruchel S; Kumar P; Wiebe L; Reilly RM
    Nucl Med Commun; 2004 Nov; 25(11):1125-30. PubMed ID: 15577592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No-carrier-added synthesis of meta-[131I]iodobenzylguanidine.
    Vaidyanathan G; Zalutsky MR
    Appl Radiat Isot; 1993 Mar; 44(3):621-8. PubMed ID: 8472027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of high-specific-activity ultratrace 123/131I-MIBG and carrier-added 123/131I-MIBG on efficacy, pharmacokinetics, and tissue distribution.
    Barrett JA; Joyal JL; Hillier SM; Maresca KP; Femia FJ; Kronauge JF; Boyd M; Mairs RJ; Babich JW
    Cancer Biother Radiopharm; 2010 Jun; 25(3):299-308. PubMed ID: 20578835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological evaluation of ring- and side-chain-substituted m-iodobenzylguanidine analogues.
    Vaidyanathan G; Shankar S; Affleck DJ; Welsh PC; Slade SK; Zalutsky MR
    Bioconjug Chem; 2001; 12(5):798-806. PubMed ID: 11562198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved effect of 131I-MIBG treatment by predosing with non-radiolabeled MIBG in carcinoid patients, and studies in xenografted mice.
    Taal BG; Hoefnagel C; Boot H; Valdés Olmos R; Rutgers M
    Ann Oncol; 2000 Nov; 11(11):1437-43. PubMed ID: 11142484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extragranular storage of the neuron blocking agent meta-iodobenzylguanidine (MIBG) in human neuroblastoma cells.
    Smets LA; Janssen M; Metwally E; Loesberg C
    Biochem Pharmacol; 1990 Jun; 39(12):1959-64. PubMed ID: 2353937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of 4-[fluorine-18]fluoro-3-iodobenzylguanidine as a positron-emitting analog of MIBG.
    Vaidyanathan G; Affleck DJ; Zalutsky MR
    J Nucl Med; 1995 Apr; 36(4):644-50. PubMed ID: 7699460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biology of metaiodobenzylguanidine interactions with human neuroblastoma cells.
    Iavarone A; Lasorella A; Servidei T; Riccardi R; Troncone L; Mastrangelo R
    J Nucl Biol Med (1991); 1991; 35(4):186-90. PubMed ID: 1823815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modification of meta-iodobenzylguanidine uptake in neuroblastoma cells by elevated temperature.
    Armour A; Mairs RJ; Gaze MN; Wheldon TE
    Br J Cancer; 1994 Sep; 70(3):445-8. PubMed ID: 8080728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical use of 131I-meta-iodo-benzylguanidine (MIBG) for the diagnosis of neuroblastoma.
    Zagar I; Mitrović S; Adanja G; Maksimović L; Ivanovski P; Han R; Kovacić K
    Med Pregl; 1993; 46 Suppl 1():74-5. PubMed ID: 8569615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meta-[211At]astatobenzylguanidine: further evaluation of a potential therapeutic agent.
    Vaidyanathan G; Strickland DK; Zalutsky MR
    Int J Cancer; 1994 Jun; 57(6):908-13. PubMed ID: 8206683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.